Among patients with IDH mutant tumours, 1p/19q codeleted tumours had greater signal heterogeneity (P = 0.002) and lower EC (P = 0.005), and MGMT-methylated tumours showed lower EC (P = 0.03). This evidence concerns the gene IDH1 and neoplasm.